13 research outputs found
Aarhus Regenerative Orthopaedics Symposium (AROS)
The combination of modern interventional and preventive medicine has led to an epidemic of ageing. While this phenomenon is a positive consequence of an improved lifestyle and achievements in a society, the longer life expectancy is often accompanied by decline in quality of life due to musculoskeletal pain and disability. The Aarhus Regenerative Orthopaedics Symposium (AROS) 2015 was motivated by the need to address regenerative challenges in an ageing population by engaging clinicians, basic scientists, and engineers. In this position paper, we review our contemporary understanding of societal, patient-related, and basic science-related challenges in order to provide a reasoned roadmap for the future to deal with this compelling and urgent healthcare problem
Erythropoietin stimuliert weder die osteogene Differenzierung noch die Proliferationsrate von mesenchymalen Stamzellen
Ageing in the musculoskeletal system: cellular function and dysfunction throughout life
The extent of ageing in the musculoskeletal system during the life course affects the quality and length of life. Loss of bone, degraded articular cartilage, and degenerate, narrowed intervertebral discs are primary features of an ageing skeleton, and together they contribute to pain and loss of mobility. This review covers the cellular constituents that make up some key components of the musculoskeletal system and summarizes discussion from the 2015 Aarhus Regenerative Orthopaedic Symposium (AROS) (Regeneration in the Ageing Population) about how each particular cell type alters within the ageing skeletal microenvironment
A single topical dose of erythropoietin applied on a collagen carrier enhances calvarial bone healing in pigs
The Osteogenic Effect of Erythropoietin on Human Mesenchymal Stromal Cells is Dose-Dependent and Involves Non-Hematopoietic Receptors and Multiple Intracellular Signaling Pathways
Aarhus regenerative orthopaedics symposium (AROS)
The combination of modern interventional and preventive medicine has led to an epidemic of ageing. While this
phenomenon is a positive consequence of an improved lifestyle
and achievements in a society, the longer life expectancy is often
accompanied by decline in quality of life due to musculoskeletal
pain and disability.
The Aarhus Regenerative Orthopaedics Symposium (AROS)
2015 was motivated by the need to address regenerative challenges in an ageing population by engaging clinicians, basic scientists, and engineers. In this position paper, we review our contemporary understanding of societal, patient-related, and basic
science-related challenges in order to provide a reasoned roadmap for the future to deal with this compelling and urgent healthcare problem